Recep Adiyaman
Vision About Experience Education Skills Publications Tools Newsletter Updates Podcasts Blog Contact CV Subscribe
All Issues
Older Newer
Daily Signal March 16, 2026 · 10 min read

Issue #68: Advantages and Limitations of AlphaFold in Structural Biology: Insights from Recent Studies.

Protein Design Digest - 2026-03-16 - Advantages and Limitations of AlphaFold in Structural Biology: Insights from Recent Studies.

Share X LinkedIn
Protein Design Daily

Building something in Protein Design?

I love collaborating on new challenges. Let's build together.

LinkedIn Email

Subscribe to Protein Design Digest

Daily curated signals from arXiv, PubMed, and BioRxiv.

Signal of the Day

Advantages and Limitations of AlphaFold in Structural Biology: Insights from Recent Studies.

Over the past three years, AlphaFold-a deep learning-based protein structure prediction system-has transformed structural biology by providing near-experimental accuracy models directly from amino acid sequences. This narrative review synthesizes applications reported in the 2022-2025 literature across human, microbial, and viral systems, drawing on peer-reviewed studies as our data source. Representative examples include modeling of SARS-CoV-2 spike and nucleocapsid proteins in virology, assisting cryo-EM interpretation of bacterial ribosomal and membrane-protein complexes in microbiology, and refining conformational hypotheses for human GPCRs in biomedicine. Across these cases, AlphaFold predictions have complemented experimental workflows by accelerating hypothesis generation, improving model fitting within ambiguous density regions (poorly resolved areas of cryo-EM maps), and guiding mutagenesis strategies to probe dynamic conformational states. We also summarize recent method extensions: AlphaFold-Multimer improves multi-chain complex assembly prediction, while molecular dynamics (MD) simulations augment AlphaFold’s static models by sampling conformational flexibility and testing stability. Despite these advances, important limitations remain-particularly for intrinsically disordered regions, protein-ligand and protein-cofactor interactions, and very large or transient assemblies-and current community benchmarks indicate that approximately one-third of residues may lack atomistic precision, underscoring uncertainty in flexible or modified segments. Framed within a clear chronological window and evidence base, our analysis highlights both the practical impact and the remaining challenges of integrating AlphaFold with experiment, outlining priorities where further methodological innovation and orthogonal validation are needed.

Why this matters: Critical for improving fold accuracy and reducing structural uncertainty in de novo design.

Also Worth Reading

Molecular embedding-based algorithm selection in protein-ligand docking.

Selecting an effective docking algorithm is highly context-dependent, and no single method performs reliably across structural, chemical, and protocol regimes. MolAS is a lightweight algorithm-selection model that predicts per-algorithm performance from pretrained protein and ligand embeddings using attentional pooling and a shallow residual decoder. With hundreds to a few thousand labelled complexes, MolAS achieves up to a 15 percentage-point absolute improvement over the single best solver (SBS) and closes 17-66% of the virtual best solver (VBS)-SBS gap across five docking benchmarks. Analyses of selection frequencies, margin-conditioned reliability, and benchmark-level oracle structure indicate that MolAS is most effective when the workflow-defined oracle landscape has low winner entropy and a reasonably separable top-solver region, but degrades under protocol mismatch that shifts solver rankings and changes the induced labels. These results suggest that, in the evaluated regime, robustness is limited less by representational capacity than by workflow- and protocol-induced instability in solver hierarchies, positioning MolAS as an in-domain selector for fixed pipelines and as a diagnostic tool for assessing when docking algorithm selection is well-posed. Scientific Contribution: MolAS introduces a controlled, embedding-based selector that reduces dependence on heavy graph encoders, enabling a cleaner separation between representational choices and workflow-defined label structure. A cross-benchmark and cross-protocol analysis links selection success and failure to oracle entropy, near-ties among top solvers, and protocol-induced ranking shifts, providing an evidence-backed diagnostic account of when docking algorithm selection is likely to yield gains. The findings differentiate this work from prior docking AS studies that report in-domain improvements under a single fixed workflow by explicitly characterising protocol dependence and motivating protocol-aware modelling as a route to stronger generalisation.

Mechanisms of Okanin against wound healing based on network pharmacology, molecular docking and molecular dynamics simulation.

Wound healing is a critical aspect of modern medicine, impacting patient health, quality of life, and healthcare resource allocation. Okanin, a flavonoid from the Asteraceae family, has shown potential in promoting wound healing. This study investigates okanin’s key molecular targets, binding affinity, and mechanisms of action using network pharmacology, molecular docking, molecular dynamics simulations, and in vivo experimental validation. Okanin’s potential targets were identified using the Comparative Toxicogenomics Database (CTD) and SwissTargetPrediction, while wound healing-related targets were sourced from GeneCards and DrugBank. Overlap analysis of these datasets revealed common targets. Key target proteins were filtered through protein-protein interaction (PPI) analysis using the STRING database. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were conducted using Metascape to build a drug-target-pathway-disease network. Molecular docking was performed with AutoDockTools, and binding affinity was evaluated through energy scores, particularly with AURKA and HDAC1. Molecular dynamics simulations with GROMACS confirmed the stability of okanin-target complexes. ADME/T properties were assessed using SwissADME and ProTox-3.0 to evaluate pharmacokinetics and toxicity. In vivo quantitative real-time PCR (qRT-PCR) was performed to assess the expression of selected target genes in a mouse wound model following topical okanin treatment. A total of 72 common targets were identified between okanin and wound healing. PPI network analysis highlighted 17 key targets, with molecular docking revealing the highest binding affinity for AURKA and HDAC1 (ΔG = - 8.8 kcal/mol for both). GROMACS were then run on the top complexes. Target-ligand stability was quantified by convergence of RMSD/Rg, sustained hydrogen-bond counts, and MM/GBSA binding free energies (AURKA, - 24.27 ± 3.65 kcal/mol; HDAC1, - 47.7 ± 1.60 kcal/mol), confirming robust interactions. SwissADME predicted good drug-likeness (MW = 288.25 g/mol; logP = 1.69; high GI and moderate skin permeability) and no P-gp liability, while ProTox-3.0 indicated low systemic toxicity (LD₅₀ = 2500 mg/kg). qRT-PCR results demonstrated that okanin treatment significantly downregulated AURKA and PIK3R1, while upregulating HDAC1, in wounded skin, supporting the predicted molecular interactions and regulatory functions. Okanin promotes wound healing through multiple molecular targets and pathways, including antioxidant, anti-inflammatory, and cell proliferation mechanisms. Its high binding affinity for AURKA and HDAC1, along with modulation of the IL-17 and AMPK signaling pathways, underscores its therapeutic potential. This study provides a comprehensive theoretical and experimental framework for the development of okanin as a topical agent for wound healing, with future research focusing on formulation development and translational applications.

Multi-omics investigation of benzo[a]pyrene in gastric cancer: comprehensive network toxicology, machine learning and molecular docking approaches.

Gastric cancer (GC) risk is shaped by environmental exposures such as benzo[a]pyrene (BaP). Here, we systematically identified BaP-toxicological targets and dissected their contribution to GC development. BaP-related targets were independently predicted with stringent filters from ChEMBL, Similarity Ensemble Approach (SEA) and PharmMapper databases, while GC-related targets were mined from the Comparative Toxicogenomics Database (CTD), GeneCards and OMIM databases. Overlapping targets were subjected to protein-protein interaction (PPI) network construction, functional enrichment analysis and molecular docking. We then integrated multi-omics data using ten clustering algorithms to identify the consensus GC subtypes, which were subsequently employed 101 machine learning combinations to develop a consensus benzo[a]pyrene-related signature (CBRS) for GC patients. As a result, we identified seven hub toxicological targets: ALB, HSP90AA1, ESR1, INS, TP53, TNF, and EGFR, underscoring their potential central roles in BaP-driven GC pathogenesis. These targets are enriched in the MAPK, Lipid and atherosclerosis, and PI3K-Akt signaling pathway. The BaP-toxicological classifiers and the CBRS prognostic model could provide useful support for risk stratification and inform personalized therapeutic strategies for GC patients. Molecular docking results suggest that BaP exhibits relatively strong binding affinity with these key toxicological targets, potentially implicating their involvement in BaP-induced gastric cancer toxicity. Therefore, this study integrates multi-dimensional omics data with advanced machine learning algorithms to establish a comprehensive analytical framework for the toxicological effects of between BaP and GC, which transcends the limitations of traditional analyses and offers unprecedented insights and evidence chains for elucidating the pathogenesis of GC.

Research & AI Updates

From the Industry

Quick Reads

In silico analysis of <i>Anacardium occidentale</i> phytochemicals: pharmacokinetics, molecular docking, and dynamics of <i>Cryptococcus neoformans</i> enzymes.

This study evaluated in silico the antifungal potential of phytochemicals from the leaves of Anacardium occidentale (cashew tree) against key enzymatic targets: farnesyltransferase (CnFTase), beta-carbonic anhydrase (β-CA), and adenylosuccinate synthetase (AdSS) from Cryptococcus neoformans . Read more →

Molecular Docking and Dynamics-Based Repurposing of Thalidomide and Lenalidomide for GSK-3β Inhibition in AD.

Glycogen synthase kinase-3 beta (GSK-3β) is a key serine/threonine protein kinase involved in several neural processes. Read more →

Unraveling the mechanism of curcumin in coronary slow flow phenomenon through network pharmacology and molecular docking.

The coronary slow flow phenomenon (CSFP) is associated with an increased risk of adverse cardiovascular events, yet standardized treatment is lacking. Read more →

In silico characterization and molecular docking of the MIOX gene in Nile tilapia (Oreochromis niloticus).

Myo-inositol oxygenase (MIOX) plays an essential role in metabolic pathways and cell processes, controls oxidative stress response mechanisms, and balances osmotic stress in aquatic organisms. Read more →

A Computational Strategy to Identify Hub Genes in Pathway Analysis of Gamma Tocotrienol-treated MCF-7 Cells and Molecular Docking Study Using Selected Phytochemicals as Therapeutic Agents.

Breast cancer is a highly prevalent malignancy in women, necessitating the discovery of novel therapeutic approaches. Read more →

Phytochemical profiling and system-level mechanistic insights into the anti-arthritic activity of Barleria cristata: Evidence from in-silico network pharmacology, molecular docking, in-vitro and in-vivo studies.

Barleria cristata L. Read more →

GeoPMB: An Interface-Aware Geometric Deep Learning Framework for Peptide-MHCI Binding Prediction with Evolutionary Insight.

The binding of peptides to class I major histocompatibility complex (MHCI) molecules is central to adaptive immunity, making the identification of immunogenic peptides a critical step in developing effective vaccines and immunotherapies against bacterial, viral, and even cancer-related diseases. Read more →

Whey protein isolate-based amphiphilic surfactin complexes: Structural, antioxidant, and interfacial properties, and molecular docking analysis.

Whey protein isolate and surfactin (WPI-S) complexes were fabricated via non-covalent interactions. Read more →

Pipeline Tip

Use local MSA generation (colabfold_search) to bypass speed bottlenecks.

Resources & Tools

Deep learning is not a magic wand, but a powerful lens for structural biology. — Recep Adiyaman

BS HF DK